Wednesday, October 14, 2026
ExploreSearch
Via News
Via News Knowledge File

Tesla Inc.

organization80% conf.·synced Oct 14, 2026

Electric vehicle and clean energy company

60
sourced metrics
1574
relationships
20
stated objectives
8
Via News reports

Every fact below is drawn from Via News's knowledge graph and linked to the source document it came from. Nothing here is unsourced. How we source →

Key metrics · each point sourced

Stock Price
375.23USD
Oct 13, 2026reference only
Market Cap
1481988668651USD
Oct 13, 2026reference only
Price 52 Week Low
298.32USD
Oct 13, 2026reference only
Stock Return Ytd
-14.3%
Oct 13, 2026reference only
Price 52 Week High
489.88USD
Oct 13, 2026reference only
Shares Outstanding
3949547394.0shares
Jul 16, 2026reference only
Net Income
1114000000.0USD
Jun 30, 2026reference only
Total Assets
148524000000.0USD
Jun 30, 2026reference only
Stockholders Equity
86858000000.0USD
Jun 30, 2026reference only
Eps
0.32USD_per_share
Jun 30, 2026reference only
Gross Profit
4751000000.0USD
Jun 30, 2026reference only
Cost Of Revenue
23485000000.0USD
Jun 30, 2026reference only
Rd Expense
2371000000.0USD
Jun 30, 2026reference only
Operating Income
398000000.0USD
Jun 30, 2026reference only
Cash
15219000000.0USD
Jun 30, 2026reference only
Total Liabilities
61005000000.0USD
Jun 30, 2026reference only
Revenue
28236000000.0USD
Jun 30, 2026reference only
Capex
2493000000.0USD
Mar 31, 2026reference only

Stated objectives

Build gigantic chip fab for AI and potentially work with Intel

source
stated

Unveil new Tesla Roadster on April 1 and begin production one year later

source
by 2027-04-01 00:00:00stated

Deliver on promises for robotaxi and Optimus humanoid robot

source
stated

Deepen collaboration on AI technology for vehicles, robotics and autonomous systems through investment in xAI

source
stated

Strategic shift from EVs to robots and autonomy-based future

source
stated

Expand robotaxi testing to Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas

source
target: 7 metro areas stated

Production of Optimus humanoid robots

source
target: production launch stated

Begin production of Optimus humanoid robots by end of year

source
by 2026-12-31 00:00:00stated

Expand robotaxi testing to Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas in first half of 2026

source
target: 7 cities by 2026-06-30 00:00:00stated

Expand robotaxi testing to Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas

source
target: 7 new cities stated

Relationship graph · 1574 connections

Competes with
313
Developed by
291
Employs
206
Covered by
161
Invested in
82
Supplies to
79
founded
62
Owns
54
subsidiary of
Tesla ChinaMag 7

Where sources disagree

We surface conflicts between sources rather than hiding them.

value conflictunresolved

Both facts measure the same attribute (cash) for the same entity (Tesla Inc.) at the same point in time (2025-12-31). Although labeled with different fiscal period categories (FY 2025 vs Q4 2025), both periods end on the same date, making them equivalent time snapshots. The values differ drastically: $16.513 billion vs $44.06 USD. Since Q4 2025 is the final quarter of FY 2025, both should report identical cash balances at period-end. A 375 million-fold magnitude difference indicates a real contradiction, likely caused by a data quality issue (unit error, miscategorization, or source error in FACT B).

source B
value conflictunresolved

Both facts report EPS (earnings per share) for Tesla Inc. for the identical fiscal period (Q1 2026) and observation date (2026-03-31), but state conflicting values: 0.13 USD/share vs. 0.41 USD. Same entity, same metric, same time period, different reported values.

source B

Via News coverage

BYD Plans 20,000 Flash Charging Stations by 2026 — Three Times Faster Than Tesla's Superchargers
June 19, 2026
Semiconductor ETFs Surge 79% as US-China Chip Race Splits Global AI Infrastructure
June 17, 2026
US 10-Year Yield Hits 4.43%, Pressuring Global Growth Stocks and Emerging Market Debt
April 26, 2026
Tesla Valuation Debate Exposes Global Divide Between Auto Metrics and AI Premium Pricing
April 21, 2026
Global chip industry redirects $50B+ toward AI packaging as consumer demand slides
April 20, 2026
U.S. Chip Giants Race China in Advanced Packaging as 2027 Rare Earth Ban Reshapes Global Supply Chains
April 19, 2026
AI Infrastructure Stocks Rise Across Four Global Markets in April 2026
April 18, 2026
Tesla's 2027 Optimus Target Signals Global Shift From Robotics Research to Commercial Markets
April 18, 2026
This Knowledge File is assembled from Via News's source-traceable knowledge graph. Metrics, objectives and relationships are extracted from primary and credible secondary documents and refreshed on a schedule. Read our methodology →
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com